Plasma Carotenoids and Retinol and Overall and Breast Cancer Risk: A Nested Case-Control Study

REFERENCES

• Namitha JJ and Negi PS: Chemistry and biotechnoly of carotenoids. Crit Rev Food Sci Nutr 50, 728–760, 2010.
   PubMed Web of Science ®Google Scholar
• Krinsky NI and Johnson EJ: Carotenoid actions and their relation to health and disease. Mol Aspects Med 26, 459–516, 2005.
   PubMedGoogle Scholar
• Chatterjee M, Roy K, Janarthan M, Das S, and Chatterjee M: Biological Activity of Carotenoids: Its Implications in Cancer Risk and Prevention. Curr Pharm Biotech 13, 180–190, 2013.
   Web of Science ®Google Scholar
• Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, et al.: Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 3, 493–500, 1994.
   PubMed Web of Science ®Google Scholar
• Aune D, Chan DS, Vieira AR, Navarro Rosenblatt DA, Vieira R, et al.: Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 96, 356–373, 2012.
   PubMed Web of Science ®Google Scholar
• Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, et al.: Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 104, 1905–1916, 2012.
   PubMed Web of Science ®Google Scholar
• Beilby J, Ambrosini GL, Rossi E, de Klerk NH, and Musk AW: Serum levels of folate, lycopene, b-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 64, 1235–1238, 2010.
   PubMed Web of Science ®Google Scholar
• Karppi J, Kurl S, Laukkanen JA, and Kauhanen J: Serum beta-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor Study. Nutr Cancer 64, 361–367, 2012.
   PubMed Web of Science ®Google Scholar
• Mondul AM, Watters JL, Mañnnisto S, Weinstein SJ, Snyder K, et al.: Serum retinol and risk of prostate cancer. Am J Epidemiol 173, 813–821, 2011.
   PubMed Web of Science ®Google Scholar
• Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, et al.: Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 86, 672–681, 2007.
   PubMed Web of Science ®Google Scholar
• Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, et al.: Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 16, 962–968, 2007.
   PubMed Web of Science ®Google Scholar
• Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M, et al.: Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiology Biomarkers & Prevention 13, 260–269, 2004.
   PubMed Web of Science ®Google Scholar
• Goodman GE, Schaffer S, Omenn GS, Chen C, and King I: The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from B-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 12, 518–526, 2003.
   PubMed Web of Science ®Google Scholar
• Kristal AR, Till C, Platz EA, Song X, King IB, et al.: Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 20, 638–646, 2011.
   PubMed Web of Science ®Google Scholar
• Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E, et al.: Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Ann Epidemiol 19, 512–518, 2009.
   PubMed Web of Science ®Google Scholar
• Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, et al.: Serum retinol and prostate cancer risk: a nested case-control study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 18, 1227–1231, 2009.
   PubMed Web of Science ®Google Scholar
• Kabat GC, Kim MY, Sarto GE, Shikany JM, and Rohan TE: Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative. Eur J Clin Nutr 66, 549–554, 2012.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Qiao YL, Dawsey SM, Buckman DW, Yang CS, et al.: Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China. Cancer Causes Control 14, 645–655, 2003.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Ross RK, Gao Yt, Qu YH, Chu XD, et al.: Prediagnostic levels of serum micronutrients in relation to risk of gastric cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 13, 1772–1780, 2004.
   PubMed Web of Science ®Google Scholar
• Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, et al.: Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer 95, 406–415, 2006.
   PubMed Web of Science ®Google Scholar
• Wakai K, Suzuki K, Ito Y, Kojima M, Tamakoshi K, et al.: Serum Carotenoids, retinol, and tocopherols, and colorectal cancer risk in a Japanese cohort: effect modification by sex for carotenoids. Nutr Cancer 51, 13–24, 2005.
   PubMed Web of Science ®Google Scholar
• Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, et al.: Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. Eur J Clin Nutr 56, 615–621, 2002.
   PubMed Web of Science ®Google Scholar
• Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al.: The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335–2342, 2004.
   PubMed Web of Science ®Google Scholar
• Le Moullec N, Deheeger M, Preziosi P, Montero P, Valeix P, et al.: Validation du manuel photos utilisé pour l’enquête alimentaire SU.VI.MAX. [Validation of the food portion sike booklet used in the SU.VI.MAX study]. Cahi Nutr Diét 31, 158–164, 1996.
   Google Scholar
• Hercberg S: Table de Composition SU.VI.MAX des Aliments. Paris, France: Les éditions INSERM/Economica, 2005
   Google Scholar
• World Health Organization: ICD-10, International classification of diseases and related health problems.10th revision. Geneva, Switzerland: World Health Organization, 1993.
   Google Scholar
• Steghens JP, van Kappel AL, Riboli E, and Collombel C: Simultaneous measurement of seven carotenoids, retinol and alpha-tocopherol in serum by hish-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 694, 71–81, 1997.
   PubMed Web of Science ®Google Scholar
• Hultén K, Van Kappel A, Winkvist A, Kaaks R, Hallmans G, et al.: Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden. Cancer Causes Control 12, 529–537, 2001.
   PubMed Web of Science ®Google Scholar
• Touvier M, Kesse E, Clavel-Chapelon F, and Boutron-Ruault MC: Dual association of beta-carotene with risk of tobacco-related cancers in a cohort of French women. J Natl Cancer Inst 97, 1338–1344, 2005.
   PubMed Web of Science ®Google Scholar
• Cui Y, Lu Z, Bai L, Shi Z, Zhao W, et al.: b-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor g expression and reactive oxygen species production in MCF-7 cancer cells. Eur J Cancer 43, 2590–2601, 2007.
   PubMed Web of Science ®Google Scholar
• Hua S, Kittler R, and White KP: Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137, 1259–1271, 2009.
   PubMed Web of Science ®Google Scholar
• Tang XY and Gudas LJ: Retinoids, retinoic acid receptors and cancer. Annu Rev Pathol 6, 64, 2011.
   Web of Science ®Google Scholar
• Tanaka T, Schnimizu M, and Moriwaki H: Cancer chemoprevention by carotenoids. Molecules 17, 3202–3242, 2012.
   PubMed Web of Science ®Google Scholar
• American Institute for Cancer Research/World Cancer Research Fund: Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.
   Google Scholar
• Kabat GC, Kim M, Adams-Campbell LL, Caan BJ, Chlebowski RT, et al.: Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr 90, 162–169, 2009.
   PubMed Web of Science ®Google Scholar
• Maillard V, Kuriki K, Lefebvre B, Boutron-Ruault MC, Lenoir GM, et al.: Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study. Int J Cancer 127, 1188–1196, 2010.
   PubMed Web of Science ®Google Scholar
• Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Duell EJ, et al.: Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up. International Journal of Cancer 131, 2910–299, 2012.
   PubMed Web of Science ®Google Scholar
• Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, et al.: Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochemical Pharmacology 50, 1485–1493, 1995.
   PubMed Web of Science ®Google Scholar
• Faure H, Fayol V, Galabert C, Grolier P, Le Moel G, et al.: Carotenoids: 1. metabolism and physiology. Ann Biol Clin (Paris) 57, 169–183, 1999.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Sugiura H, Inaba R, Nishikawa A, Murakami A, et al.: Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis 20, 1471–1476, 1999.
   PubMed Web of Science ®Google Scholar
• Lorenzo Y, Azqueta A, Luna L, Bonilla F, Dominguez G, et al.: The carotenoid b-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells. Carcinogenesis 30, 308–314, 2009.
   PubMed Web of Science ®Google Scholar
• Chaiter Y, Gruber SB, Ben-Amotz A, Almog R, Rennert HS, et al.: Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes Control 20, 1327–1338, 2009.
   PubMed Web of Science ®Google Scholar
• Park SY, Nomura A, Murphy SP, Wilkens LR, Henderson BE, et al.: Carotenoid Intake and colorectal Cancer Risk: The Multiethnic Cohort Study. J Epidemiol 19, 63–71, 2009.
   PubMed Web of Science ®Google Scholar
• Nagao A: Oxidative conversion of carotenoids to retinoids and other products. J Nutr 134, 237S–240S, 2004.
   PubMed Web of Science ®Google Scholar
• Yeh SL and Hu ML: Antioxidant and pro-oxidant effects of lycopene in comparison with b-carotene on oxidant-induced damage in Hs68 cells. J Nutr Biochem 11, 548–554, 2000.
   PubMed Web of Science ®Google Scholar
• Yeh SL, Hu ML, and Huang CS: Lycopene enhances UVA-induced DNA damage and expression of heme oxygenase-1 in cultured mouse embryo fibroblasts. Eur J Nutr 44, 365–370, 2005.
   PubMed Web of Science ®Google Scholar
• Yeh S and Hu ML: Induction of oxidative DNA damage in human foreskin fibroblast Hs68 cells by oxidized beta-Carotene and lycopene. Free Radic Res 35, 203–213, 2001.
   PubMed Web of Science ®Google Scholar
• Hwang ES and Bowen PE: Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23, 97–105, 2005.
   PubMed Web of Science ®Google Scholar
• Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z, et al.: Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Letters 164, 1–6, 2001.
   PubMed Web of Science ®Google Scholar
• Dingley KH, Ubick EA, Chiarappa-Zucca ML, Nowell S, Abel S, et al.: Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and Phase II hepatic enzymes. Nutr Cancer 46, 212–221, 2003.
   PubMed Web of Science ®Google Scholar
• Napolitano M, De Pascale C, Wheeler-Jones C, Botham KM, and Bravo E: Effects of lycopene on the induction of foam cell formation by modified LDL. Am J Physiol 293, E1820–E1827, 2007.
   Web of Science ®Google Scholar
• Veeramachaneni S, Ausman LM, Choi SW, Russell RM, and Wang XD: High dose lycopene supplementation increases hepatic cytochrome P4502E1 protein and inflammation in alcohol-fed rats. J Nutr 138, 1329–1335, 2008.
   PubMed Web of Science ®Google Scholar
• Susuki K, Ito Y, Hashimoto S, Kawado M, Inoue T, et al.: Association of serum retinol and carotenoids with insulin-like growth factors and insulin-like growth factor binding protein-3 among control subjects of a nested case-control study in the Japan Collaborative Cohort Study. Asian Pac J Cancer Prev 10(Suppl), 29–35, 2009.
   PubMed Web of Science ®Google Scholar